Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

01-09-2021

Vaccine platform technologies – Learnings from the COVID-19 pandemic

NDA Advisory Board Members, Steffen Thirstrup and Pieter Neels provide an insight into current vaccine platform technology and how the rapid response to tackle emerging infectious diseases can be further improved.
04-06-2021

Patient Access in the real world: Addressing challenges and opportunities.

NDA Advisory Board Members, Mel Walker and Yngve Mikkelsen provide an insight into how global events can impact patient access in a real-world setting.
11-05-2021

The UK regulatory landscape: Gateways leading to new beginnings

Dr Thomas Lönngren provides his perspective and early insights on the new UK Regulatory framework implemented by the MHRA.
05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 2

In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA addresses why, when, and how to interact with the regulatory agencies to optimize the success of clinical development of a new medicinal product.
05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 1

In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA presents the fundamentals of designing a successful clinical trial.
23-04-2021

Project Orbis: What a pharmaceutical company needs to know

In this article, NDA's Senior Consultant and Project Orbis lead Claudia Reichle provides background and practical information on the FDA driven initiative Project Orbis.